Aiforia has received a patent from the United States Patent and Trademark Office (USPTO) for its high-speed artificial intelligence (AI) training tool Annotation Assistant in medical image analysis.

The tool is developed for the accelerated development of AI models for image analysis in pathology.

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

It works by scanning images of areas that would offer the vital training data during AI model development.

Furthermore, it improves the quality of the AI model and is useful in analysing rare cases and large data sets with heavy variation.

Aiforia specialises in developing deep learning AI solutions for image analysis across a variety of medical domains.

The company’s cloud-based software, Aiforia Create, is designed to help medical professionals to create AI models for any image analysis application without the need to code or use dedicated hardware.

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Aiforia CTO Tuomas Ropponen said: “AI is transforming medical image analysis, but the misconception is that it is difficult and time-consuming to get started with it. Aiforia Create has removed these barriers, and with the Annotation Assistant tool, we have made it even easier and faster for pathologists, scientists, and researchers to train AI models for various types of image analysis applications.”

AI-assisted image analysis is increasingly used in range of areas, including oncology and neuroscience.

Artificial intelligence models accelerate and standardise image analysis in addition to offering increasingly accurate quantitative data. It also assists healthcare professionals in research and clinical labs and enhance their ability to make discoveries, decisions and diagnoses.

Aiforia COO Kaisa Helminen said: “What makes Aiforia unique is the investment we make in our offering. We not only invest in developing software that is very user friendly, simplifying the use of AI in medical image analysis, but also in providing technology that is cutting-edge.

“This patent truly signifies our commitment to bringing powerful, complex AI techniques straight to the hands of medical professionals.”

Medical Device Network Excellence Awards - Nominations Closed

Nominations are now closed for the Medical Device Network Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact

Excellence in Action
HemoSonics has won the 2025 Marketing Award for its impactful promotion of theQuantra Hemostasis System and leadership in blood management education. See how targeted campaigns, thought leadership content, and hands on clinician training are accelerating Quantra’s market traction and shaping the future of hemostasis testing.

Discover the Impact